BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15515587)

  • 1. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.
    von Euler H; Einarsson R; Olsson U; Lagerstedt AS; Eriksson S
    J Vet Intern Med; 2004; 18(5):696-702. PubMed ID: 15515587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
    von Euler HP; Ohrvik AB; Eriksson SK
    Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma thymidine kinase activity in dogs with lymphoma and leukemia.
    Nakamura N; Momoi Y; Watari T; Yoshino T; Tsujimoto H; Hasegawa A
    J Vet Med Sci; 1997 Oct; 59(10):957-60. PubMed ID: 9362053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thymidine kinase activity in clinically healthy and diseased horses: a potential marker for lymphoma.
    Larsdotter S; Nostell K; von Euler H
    Vet J; 2015 Aug; 205(2):313-6. PubMed ID: 25744802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma.
    Taylor SS; Dodkin S; Papasouliotis K; Evans H; Graham PA; Belshaw Z; Westberg S; von Euler HP
    J Feline Med Surg; 2013 Feb; 15(2):142-7. PubMed ID: 23076596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine kinase assay in canine lymphoma.
    Elliott JW; Cripps P; Blackwood L
    Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma.
    Madewell BR
    J Vet Intern Med; 2004; 18(5):595-6. PubMed ID: 15515571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum thymidine kinase activity as a useful marker for bovine leukosis.
    Sakamoto L; Ohbayashi T; Matsumoto K; Kobayashi Y; Inokuma H
    J Vet Diagn Invest; 2009 Nov; 21(6):871-4. PubMed ID: 19901293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma.
    Boyé P; Floch F; Serres F; Geeraert K; Clerson P; Siomboing X; Bergqvist M; Sack G; Tierny D
    J Vet Intern Med; 2019 Jul; 33(4):1728-1739. PubMed ID: 31129922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
    Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
    Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
    Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
    Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
    Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
    PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
    He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
    Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy.
    Alexandrakis I; Tuli R; Ractliffe SC; Tappin SW; Foale RD; Roos A; Slater KJ
    Vet Comp Oncol; 2017 Mar; 15(1):6-17. PubMed ID: 25319380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V trial.
    Brown RD; Joshua DE; Nelson M; Gibson J; Dunn J; MacLennan IC
    Br J Haematol; 1993 Jun; 84(2):238-41. PubMed ID: 8398824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome].
    Aul C; Germing U; Gattermann N; Söhngen D; Heyll A
    Dtsch Med Wochenschr; 1996 Sep; 121(37):1113-8. PubMed ID: 8925725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thymidine kinase as a marker of disease activity in patients with multiple myeloma.
    Brown RD; Joshua DE; Ioannidis RA; Kronenberg H
    Aust N Z J Med; 1989 Jun; 19(3):226-32. PubMed ID: 2528340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alpha 1-acid glycoprotein concentrations before and after relapse in dogs with lymphoma treated with doxorubicin.
    Hahn KA; Freeman KP; Barnhill MA; Stephen EL
    J Am Vet Med Assoc; 1999 Apr; 214(7):1023-5. PubMed ID: 10200796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer.
    Felix K; Hinz U; Dobiasch S; Hackert T; Bergmann F; Neumüller M; Gronowitz S; Bergqvist M; Strobel O
    Pancreas; 2018 Jan; 47(1):72-79. PubMed ID: 29189449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid A is not a marker for relapse of multicentric lymphoma in dogs.
    Merlo A; Rezende BC; Franchini ML; Monteiro PR; Lucas SR
    Vet Clin Pathol; 2008 Mar; 37(1):79-85. PubMed ID: 18366549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.